The multidisciplinary team approach to rectal cancer has been validated to improve the outcome of patients with rectal cancer. 1,2 The radiologist's contribution in this arena is accurate staging and restaging local extent of disease. These are vital to improving patient survival with rectal cancer while at the same time lowering the morbidity and mortality which may be associated with local recurrence and metastatic disease. Accurate staging prevents undertreatment or overtreatment of rectal cancer. Current evidence-based guidelines support the use of either transrectal ultrasound (TRUS) or magnetic resonance imaging (MRI) assessment of local disease extent. Despite these guidelines, recent research confirms appropriate local staging remains underutilized, particularly in the hands of general surgeons. 3 MRI has supplanted TRUS for staging in many institutions. MRI with rectal cancer protocol modification is now the preferred modality for rectal cancer staging and restaging in most specialty institutions. The aim of this article is (1) to highlight the utility of MRI for these purposes, emphasizing synoptic reporting, and (2) to examine barriers and solutions to appropriate MRI utilization in rectal cancer care.
Magnetic Resonance Imaging StagingCurrent TNM staging in rectal cancer derives stage groupings based on (1) the depth of tumor invasion into the rectal wall and surrounding structures, including the peritoneum and surrounding viscera; (2) the presence and number of involved lymph nodes; and (3) the presence of metastatic disease to distant organs, distant lymph nodes, or distant portions of the peritoneum. The superior soft tissue contrast achieved with state-of-the-art rectal protocol MRI allows for measurement of the tumor depth of invasion (DOI) (T stage), determination of the relationship of the most invasive component of the tumor to the mesorectal fascia, and elucidation of the tumor's relationship to the sphincter complex, peritoneal reflection, and perirectal venous plexus (►Fig. 1A, B). 4 Furthermore, MRI is able to assess for lymph nodes and tumor deposits in the tissues beyond the mesorectal fascia, including the pelvic sidewall, which, if unaddressed, are a source of residual and/ or recurrent disease (►Fig. 2). 5-7 Though not currently included in current staging guidelines, the presence of extensive extramural vascular invasion as determined by MRI places patients at high risk for metastatic disease and is associated with poor survival. 8 The inception of minimally invasive treatment strategies, such as local transanal excision, underscores the need to accurately assess a tumor's relationship to the peritoneal reflection and the layers of the rectal wall muscle. Two large studies have recently confirmed the ability of MRI to determine the location of the tumor with respect to the anterior peritoneal reflection. MRI is able to identify the peritoneal reflection between 75 and 90% of cases. 9,10 Given the complexity and number of parameters that need to be addressed when interpreting rectal ...